Covered recipient · General Payments record
CLAIRE SUZANNE MOFFITT
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$825.21
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $520.27 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.38 | 21 |
| Acerta Pharma LLC | $88.66 | 3 |
| Novo Nordisk AS | $68.22 | 4 |
| Lilly USA, LLC | $67.12 | 4 |
| HARMONY BIOSCIENCES LLC | $43.59 | 1 |
| Amgen Inc. | $33.47 | 2 |
| Insulet Corporation | $20.93 | 1 |
| Supernus Pharmaceuticals, Inc. | $17.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $2.58 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720771 | CMS |
| ABBVIE INC. | $1.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720773 | CMS |
| ABBVIE INC. | $6.36 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720775 | CMS |
| ABBVIE INC. | $6.90 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720777 | CMS |
| ABBVIE INC. | $6.25 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720779 | CMS |
| ABBVIE INC. | $1.92 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720781 | CMS |
| ABBVIE INC. | $3.88 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720783 | CMS |
| ABBVIE INC. | $5.53 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720785 | CMS |
| ABBVIE INC. | $2.98 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720787 | CMS |
| ABBVIE INC. | $67.24 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720789 | CMS |
| ABBVIE INC. | $4.55 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720791 | CMS |
| ABBVIE INC. | $7.12 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720793 | CMS |
| ABBVIE INC. | $2.47 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720795 | CMS |
| ABBVIE INC. | $6.20 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720797 | CMS |
| ABBVIE INC. | $5.83 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720799 | CMS |
| ABBVIE INC. | $6.14 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720801 | CMS |
| ABBVIE INC. | $5.95 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720803 | CMS |
| ABBVIE INC. | $6.10 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720805 | CMS |
| ABBVIE INC. | $18.84 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720807 | CMS |
| ABBVIE INC. | $7.44 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720809 | CMS |
| ABBVIE INC. | $5.10 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107720811 | CMS |
| Amgen Inc. | $17.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115938143 | CMS |
| Amgen Inc. | $16.47 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115938149 | CMS |
| AstraZeneca Pharmaceuticals LP | $55.72 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105839721 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.34 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104757948 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.60 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104202355 | CMS |
| HARMONY BIOSCIENCES LLC | $43.59 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126069616 | CMS |
| Insulet Corporation | $20.93 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116803440 | CMS |
| Lilly USA, LLC | $17.07 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614679 | CMS |
| Lilly USA, LLC | $17.12 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135591236 | CMS |
| Lilly USA, LLC | $15.81 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135614681 | CMS |
| Lilly USA, LLC | $17.12 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135546059 | CMS |
| Novo Nordisk Inc | $17.81 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100230938 | CMS |
| Novo Nordisk Inc | $15.49 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100575878 | CMS |
| Novo Nordisk Inc | $17.93 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100632563 | CMS |
| Novo Nordisk Inc | $16.99 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100226600 | CMS |
| Supernus Pharmaceuticals, Inc. | $17.90 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147849074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.